search
Back to results

HIS Alternative II - UK Site

Primary Purpose

Heart Failure, Left Bundle-Branch Block

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
HIS/LBB pacing
LV pacing
Sponsored by
Imperial College Healthcare NHS Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Heart Failure

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Patients over 18 years of age, ischemic or non-ischemic cardiomyopathy with LVEF ≤ 35% assessed by echocardiography, NYHA class II-IV heart failure symptoms despite optimal medical treatment and Either planned new implantation of a biventricular pacing system (CRT-P or CRT-D), where the ECG is with sinus rhythm and a typical left bundle branch block (see definition below) Or planned upgrade of an existing pacemaker or ICD to a biventricular pacing system (CRT-P or CRT-D), where the ECG is with sinus rhythm and a typical left bundle branch block or there has been> 90% right ventricular pacing from an existing pacemaker for at least 2 months prior to enrollment Signed informed consent Typical left bundle branch block: QRS width > 130 msec for women and > 140 msec for men QS or rS pattern in leads V1 and V2, and mid-QRS plateau phase with or without extras in at least 2 of leads V1, V2, V5, V6, I, and aVL Exclusion Criteria: Existing biventricular pacing system Permanent atrial fibrillation Severe renal failure with eGFR < 30 ml/min AMI or CABG within the last three months The patient does not want to participate

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    HIS/LBB pacing

    LV pacing

    Arm Description

    In this arm a right ventricular (RV) lead or implantable cardioverter defibrillator (ICD) lead is placed first and then implantation of a HIS-pacing lead is attempted. If it is not possible to find and pace HIS, to correct the LBBB or the threshold for correcting the LBBB is > 2.5 V at 1 ms, implantation of a LBB-pacing lead is attempted instead. If that is not possible either, a left ventricular (LV) lead is implanted. Intervention: Device: HIS/LBB pacing

    In this arm an RV-lead or ICD-lead is placed first and then implantation of a LV-pacing lead is attempted. If this is not possible due to anatomical difficulties (no coronary sinus (CS) access, no available branches other than v cordis anterior or v cordis media) or electrical difficulties (no capture below 4 V at 1.0 msec or phrenic nerve stimulation < 2x pacing threshold), implantation of a HIS-pacing lead is attempted instead. If that is not possible or the threshold for correcting the LBBB is > 2.5 V at 1 ms, implantation of a LBB-pacing lead is attempted instead. Intervention: Device: LV pacing

    Outcomes

    Primary Outcome Measures

    Change in Left ventricular end-systolic volume
    Echocardiographic response after 6 months defined as decrease in left ventricular systolic volume of ≥ 15% of baseline
    Success rate of implanting a HIS-bundle lead with capture of the left bundle branch or a LBB-lead with narrowing of QRS
    The success rate of implanting a pacing lead to the HIS-bundle with capture of the left bundle at a threshold < 2.5 V at 1 ms or implantation of a LBB lead with narrowing of the QRS duration and maintaining this effect at 6 month follow-up

    Secondary Outcome Measures

    Change in LVEF and left ventricular chamber dimensions
    Echocardiographic response assessed by chamber dimensions and LVEF on a continuous scale
    Change in 6-min hall-walk test
    Functional response after 6 months defined as an increase in 6-min walking distance of ≥ 20% of the initial value
    Change in NYHA class
    Symptomatic response after 6 months defined as a fall in NYHA class of ≥ 1
    Change in Minnesota Living with Heart Failure score
    Change in well-being after 6 months defined as a decrease in Minnesota Living With Heart Failure score of ≥ 15% of baseline
    Shortening of QRS duration
    Shortening the duration of the QRS complex defined as the widest paced QRS complex rated at 12-lead ECG after 6 months
    Change in NT-pro BNP value
    Change in NT-pro BNP value
    Complications
    Device-related complications (periprocedural: electrode reoperation, pneumothorax, hemothorax, pericardial bleeding/tamponade and later (after 30 days post implantation): LV/HIS electrode reoperation, change of device due to battery depletion and infection requiring extraction).

    Full Information

    First Posted
    March 16, 2023
    Last Updated
    April 13, 2023
    Sponsor
    Imperial College Healthcare NHS Trust
    Collaborators
    Rigshospitalet, Denmark
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05814263
    Brief Title
    HIS Alternative II - UK Site
    Official Title
    Direct HIS/LBB Pacing as an Alternative to Biventricular Pacing in Patients With Symptomatic Heart Failure Despite Optimal Medical Treatment and ECG With Typical Left Bundle Branch Block
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    April 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    April 2023 (Anticipated)
    Primary Completion Date
    March 2024 (Anticipated)
    Study Completion Date
    September 2024 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Imperial College Healthcare NHS Trust
    Collaborators
    Rigshospitalet, Denmark

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The study will investigate the feasibility of using direct HIS pacing or left bundle branch pacing (LBB pacing) as an alternative to biventricular pacing in patients with symptomatic heart failure and an ECG with a typical left bundle branch block pattern.
    Detailed Description
    Biventricular pacing has for more than a decade been standard of care for patients with HFrEF, LVEF < 35%, NYHA II-IV despite optimal medical treatment and an ECG with left bundle branch block (LBBB). However, it is not always ideal because of several drawbacks such as phrenic nerve capture, inability to reach late activated areas and many more. Direct HIS pacing can in many cases capture the left bundle and provide normal electrical activation of the left ventricle but sometimes with high pacing thresholds. Recently direct left bundle branch pacing has shown promise with synchronous activation of the left ventricle at low pacing thresholds. In the present study the investigators randomize 125 patients in one center to either conventional CRT (45 patients) or HIS/LBB pacing (80 patients). In the HIS/LBB arm, direct HIS-pacing is attempted first but if its not possible or the pacing threshold for capturing the left bundle branch is > 2.5 V at 1 ms the investigators switch to placing a LBB-lead. Power calculation for non-inferiority: With the 50 patients in the first His Alternative study (25 Biv-CRT og 25 His-CRT) the investigators observed a fall in systolic volumes of 34% and 46% with a standard deviation of 13-16%. Using these numbers it would take at least 108 patients to be 90% sure that the lower limit of a one-sided 97.5% confidence interval (equal to a 95% two-sided confidence interval) would be over the non-inferiority limit of -10%.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Heart Failure, Left Bundle-Branch Block

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantOutcomes Assessor
    Masking Description
    The patient and the staff performing and evaluating echocardiography and hall-walk tests are blinded to the treatment arm
    Allocation
    Randomized
    Enrollment
    40 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    HIS/LBB pacing
    Arm Type
    Experimental
    Arm Description
    In this arm a right ventricular (RV) lead or implantable cardioverter defibrillator (ICD) lead is placed first and then implantation of a HIS-pacing lead is attempted. If it is not possible to find and pace HIS, to correct the LBBB or the threshold for correcting the LBBB is > 2.5 V at 1 ms, implantation of a LBB-pacing lead is attempted instead. If that is not possible either, a left ventricular (LV) lead is implanted. Intervention: Device: HIS/LBB pacing
    Arm Title
    LV pacing
    Arm Type
    Active Comparator
    Arm Description
    In this arm an RV-lead or ICD-lead is placed first and then implantation of a LV-pacing lead is attempted. If this is not possible due to anatomical difficulties (no coronary sinus (CS) access, no available branches other than v cordis anterior or v cordis media) or electrical difficulties (no capture below 4 V at 1.0 msec or phrenic nerve stimulation < 2x pacing threshold), implantation of a HIS-pacing lead is attempted instead. If that is not possible or the threshold for correcting the LBBB is > 2.5 V at 1 ms, implantation of a LBB-pacing lead is attempted instead. Intervention: Device: LV pacing
    Intervention Type
    Device
    Intervention Name(s)
    HIS/LBB pacing
    Intervention Description
    3830 lead to HIS or LBB
    Intervention Type
    Device
    Intervention Name(s)
    LV pacing
    Intervention Description
    LV lead in a CS branch
    Primary Outcome Measure Information:
    Title
    Change in Left ventricular end-systolic volume
    Description
    Echocardiographic response after 6 months defined as decrease in left ventricular systolic volume of ≥ 15% of baseline
    Time Frame
    6 months
    Title
    Success rate of implanting a HIS-bundle lead with capture of the left bundle branch or a LBB-lead with narrowing of QRS
    Description
    The success rate of implanting a pacing lead to the HIS-bundle with capture of the left bundle at a threshold < 2.5 V at 1 ms or implantation of a LBB lead with narrowing of the QRS duration and maintaining this effect at 6 month follow-up
    Time Frame
    6 months
    Secondary Outcome Measure Information:
    Title
    Change in LVEF and left ventricular chamber dimensions
    Description
    Echocardiographic response assessed by chamber dimensions and LVEF on a continuous scale
    Time Frame
    6 months
    Title
    Change in 6-min hall-walk test
    Description
    Functional response after 6 months defined as an increase in 6-min walking distance of ≥ 20% of the initial value
    Time Frame
    6 months
    Title
    Change in NYHA class
    Description
    Symptomatic response after 6 months defined as a fall in NYHA class of ≥ 1
    Time Frame
    6 months
    Title
    Change in Minnesota Living with Heart Failure score
    Description
    Change in well-being after 6 months defined as a decrease in Minnesota Living With Heart Failure score of ≥ 15% of baseline
    Time Frame
    6 months
    Title
    Shortening of QRS duration
    Description
    Shortening the duration of the QRS complex defined as the widest paced QRS complex rated at 12-lead ECG after 6 months
    Time Frame
    6 months
    Title
    Change in NT-pro BNP value
    Description
    Change in NT-pro BNP value
    Time Frame
    6 months
    Title
    Complications
    Description
    Device-related complications (periprocedural: electrode reoperation, pneumothorax, hemothorax, pericardial bleeding/tamponade and later (after 30 days post implantation): LV/HIS electrode reoperation, change of device due to battery depletion and infection requiring extraction).
    Time Frame
    6 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Patients over 18 years of age, ischemic or non-ischemic cardiomyopathy with LVEF ≤ 35% assessed by echocardiography, NYHA class II-IV heart failure symptoms despite optimal medical treatment and Either planned new implantation of a biventricular pacing system (CRT-P or CRT-D), where the ECG is with sinus rhythm and a typical left bundle branch block (see definition below) Or planned upgrade of an existing pacemaker or ICD to a biventricular pacing system (CRT-P or CRT-D), where the ECG is with sinus rhythm and a typical left bundle branch block or there has been> 90% right ventricular pacing from an existing pacemaker for at least 2 months prior to enrollment Signed informed consent Typical left bundle branch block: QRS width > 130 msec for women and > 140 msec for men QS or rS pattern in leads V1 and V2, and mid-QRS plateau phase with or without extras in at least 2 of leads V1, V2, V5, V6, I, and aVL Exclusion Criteria: Existing biventricular pacing system Permanent atrial fibrillation Severe renal failure with eGFR < 30 ml/min AMI or CABG within the last three months The patient does not want to participate
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Daniel Keene, MBChB
    Phone
    020 3313 1000
    Email
    daniel.keene@nhs.net
    First Name & Middle Initial & Last Name or Official Title & Degree
    mohamed zuhair, MBBS
    Phone
    020 3313 1000
    Email
    m.zuhair@nhs.net

    12. IPD Sharing Statement

    Plan to Share IPD
    Yes
    IPD Sharing Plan Description
    Will share data with international arm of the project NCT04409119
    IPD Sharing Time Frame
    6 months following final recruitment

    Learn more about this trial

    HIS Alternative II - UK Site

    We'll reach out to this number within 24 hrs